4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-029609
Chief Medical Officer sold 9,921 shares at an average $25.86 ($256,585)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Farwell Wildon · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-07 | Sale : show line 1 in the form 10b5-1 | −8,364 | $25.80 | $215,791 | 154,732 | D |
| 2024-03-07 | Sale : show line 2 in the form 10b5-1 | −1,557 | $26.20 | $40,793 | 153,175 | D |
| Open-market sales · 9,921 sh · avg $25.86 · $256,585 | ||||||
Loading xslF345X05/ownership.xml…